<DOC>
	<DOC>NCT00427687</DOC>
	<brief_summary>This study will evaluate the effect of AGG-523 administration on biomarkers related to osteoarthritis. Safety and tolerability of AGG-523 will also be assessed.</brief_summary>
	<brief_title>Study Evaluating AGG-523 in Subjects With Osteoarthritis</brief_title>
	<detailed_description />
	<mesh_term>Osteoarthritis</mesh_term>
	<criteria>Inclusion: Mild to moderate Osteoarthritis of the target knee. Subjects must be generally healthy but enrolled with stable chronic illness if well controlled.</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2008</verification_date>
</DOC>